We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

Adriana V. Tibbitts


Adriana V. Tibbitts

Adriana Tibbitts is a corporate and commercial lawyer who uses her deep knowledge of the life sciences industry to help clients meet their business goals and identify practical, creative solutions in response to industry-specific issues.

As counsel in our Corporate practice group and a member of our global Life Sciences and Healthcare industry sector team, Adriana provides transactional, commercial, and corporate advice to pharmaceutical, biotechnology, and medical device companies at all stages of development as well as universities, academic medical centers, venture capital funds, and their portfolio companies.

A significant part of Adriana's practice is focused on licensing and collaboration arrangements, technology transfer, and other complex intellectual property-related transactions. She also advises clients in connection with other transactional matters, including joint ventures, mergers and acquisitions, financing transactions, and the acquisition of pharmaceutical royalty streams. Adriana has particular knowledge handling transactions involving digital health products and is a member of our digital health team.

In addition to her transactional work, Adriana regularly drafts and negotiates commercial contracts specific to the life sciences industry, including manufacturing, co-promotion, material transfer, research, and clinical trial agreements. She also represents venture capital funds and their portfolio companies in the life sciences industry on general corporate matters and equity and debt financings.

Adriana has been interested in healthcare since majoring in public health at Johns Hopkins University. While in law school, she was awarded a health law certificate for completing the law and healthcare program at the University of Maryland Francis King Carey School of Law. Prior to entering law school, Adriana traveled across the United States as a trial clerk with the U.S. Tax Court.

Representative experience

Advising Novartis in its acquisition of GlaxoSmithKline's oncology business and divestiture of its animal health business to Eli Lilly

Advising the University of Pennsylvania in connection with its collaboration with Novartis to develop CAR T-Cell immunotherapies to treat cancer

Advising clients, including Immune Design, TESARO, and Rexahn Pharmaceuticals, in licensing and collaboration agreements for the development of novel therapeutics and medical devices

Advising a high-technology company in connection with its life science business ventures, including exclusive licenses and joint ventures, to develop digital health products

Advising growth-stage companies with respect to commercial and corporate matters

Advising a private equity fund in its acquisition of multiple pharmaceutical royalty streams

Advising Apple Tree Partners with respect to its investments in multiple life sciences companies

Advising Braeburn Pharmaceuticals in connection with its US$110m mezzanine round of financing

Education and admissions


  • J.D., cum laude, University of Maryland School of Law, 2009
  • B.A., Johns Hopkins University, 2004

Bar admissions and qualifications

  • Maryland
Loading data